{"id":"11c-l-deprenyl-d2","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL8663","moleculeType":"Small molecule","molecularWeight":"187.29"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"11C-L-deprenyl-D2 is a radiolabeled derivative of the selective norepinephrine reuptake inhibitor deprenyl, which is used to study the brain's norepinephrine system.","oneSentence":"Selective norepinephrine reuptake inhibitor","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T05:47:28.724Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Depression"}]},"trialDetails":[{"nctId":"NCT01701089","phase":"PHASE1","title":"A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2012-09","conditions":"Healthy Volunteer, Alzheimer's Disease","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"11C-L-deprenyl-D2","genericName":"11C-L-deprenyl-D2","companyName":"Hoffmann-La Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Selective norepinephrine reuptake inhibitor Used for Depression.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}